DIRS.INFO The most relevant business & tech news

☆ Expensive Drugs From Pfizer, Other Companies Targeted for First U.S. Price Negotiations
▼ + stars: | 2023-08-29 | by ( Jared S. Hopkins | Stephanie Armour | ) www.wsj.com time to read: 1 min

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/health/pharma/expensive-drugs-from-pfizer-other-companies-targeted-for-first-u-s-price-negotiations-9942b20b

Persons: Dow Jones Organizations: pfizer

☆ Expensive Drugs Targeted for First U.S. Price Negotiations
▼ + stars: | 2023-08-29 | by ( Jared S. Hopkins | Stephanie Armour | ) www.wsj.com time to read: 1 min

Persons: Dow Jones Organizations: pfizer

He said that once implemented, the prices on negotiated drugs will decrease for up to 9 million seniors who currently pay as much as $6,497 in out-of-pocket costs per year for these prescriptions. This kicks off the negotiation process for the 10 drugs whose new prices will go into effect in 2026. U.S. laws had prohibited Medicare from negotiating pharmaceutical prices as part of its prescription drug program that began about 20 years ago. CMS Director Dr. Meena Seshamani said Medicare plans to use a review process to make sure insurance companies keep clinically appropriate access to negotiated drugs. Two analysts said they expect the negotiated prices to move beyond Medicare and affect commercial markets for these drugs by 2026, when they come into effect.

Persons: Joe Biden, Jonathan Ernst, Biden, Joe Biden’s, Januvia, Xarelto, Johnson, Boehringer Ingelheim, Eli Lilly's, Jardiance, Mohit Bansal, Entresto, Eli Lilly, Merck, Bristol Myers, Giovanni Caforio, Caforio, enrollees, Meena Seshamani, Stelara, Amgen, Evan Seigerman, Patrick Wingrove, Mike Erman, Manas Mishra, Nandita Bose, Caroline Humer, Bill Berkrot Organizations: Social Security, University of Tampa, REUTERS, U.S, Bristol Myers Squibb, Pfizer, Merck, Co's, Johnson, Novo Nordisk, NYSE Arca Pharmaceutical, U.S . Centers, Medicare, Medicaid Services, Reuters Graphics Wells, Novartis, AstraZeneca, Bristol, J, U.S . Department of Health, Human Services, BMO Capital, Thomson Locations: Tampa , Florida, U.S, Amgen's, Jardiance, Germany, Bengaluru, Washington

☆ These are the top 10 things to watch in the stock market Tuesday
▼ + stars: | 2023-08-29 | by ( Jeff Marks | ) www.cnbc.com time to read: +4 min

Oracle (ORCL) upgraded to buy from neutral at UBS with a price target of $140. Piper Sandler increases its Broadcom (AVGO) price target to $925 from $830 ahead of earnings Thursday after the bell. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: telco, Corie Barry, Piper Sandler, Bernstein, Jim Cramer's, Jim Cramer, Jim, Marlena Sloss Organizations: Oracle, UBS, Nvidia, Investing, Nasdaq, Verizon, Citi, underperform, Biden Administration, Medicare, pharma, DuPont, Broadcom, Jim Cramer's Charitable, CNBC, Bloomberg, Getty Locations: Airbnb, Salesforce, San Francisco , California

☆ Mukesh Ambani’s succession planning is a bonus
▼ + stars: | 2023-08-29 | by ( ) www.reuters.com time to read: +2 min

Mukesh Ambani (R), Chairman and Managing Director of Reliance Industries, poses with (from 2nd R to L) wife Nita Ambani, children Isha Ambani, Anant Ambani, and Akash Ambani before addressing the company's annual general meeting in Mumbai, India July 21, 2017. REUTERS/Shailesh Andrade Acquire Licensing RightsMUMBAI, Aug 29 (Reuters Breakingviews) - The bar for Mukesh Ambani to impress is rising, including on succession. Planning is sensible, yet Reliance shares closed down 1.1%. Here, the top challenge may be getting public shareholders to match the $100 billion valuation the Qataris have set for the shopping unit. They do not reflect the views of Reuters News, which, under the Trust Principles, is committed to integrity, independence, and freedom from bias.

Persons: Mukesh Ambani, Nita Ambani, Isha Ambani, Anant Ambani, Akash Ambani, Shailesh Andrade, Ambani, Isha, Akash, Anant, That’s, Shritama Bose, Didi, Una Galani, Thomas Shum Organizations: Reliance Industries, REUTERS, Rights, Reuters, Reliance, Reliance Retail, Jio Financial Services, X, White, Thomson Locations: Mumbai, India

☆ Biden administration unveils first 10 drugs subject to Medicare price negotiations
▼ + stars: | 2023-08-29 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +7 min

Fiasp and NovoLog, insulins made by Novo Nordisk The Medicare negotiations are the centerpiece of the Biden administration's efforts to rein in the rising cost of medications in the U.S. Drugmakers such as Merck and Johnson & Johnson and their supporters aim to derail the negotiations, filing at least eight lawsuits in recent months seeking to declare the policy unconstitutional. Drugmakers' legal challengesMerck, Johnson & Johnson, Bristol-Myers Squibb and Astellas Pharma are among the companies suing to halt the negotiation process. The suits make similar and overlapping claims that Medicare negotiations are unconstitutional. Biden and his top health officials have embraced the lawsuits as evidence that they're making progress in the fight to cut drug prices.

Persons: Biden, Joe Biden's, Boehringer Ingelheim, Johnson Januvia, Merck Farxiga, Novartis Enbrel, Amgen Imbruvica, AbbVie Stelara, Janssen, insulins, Johnson, Leigh Purvis, Drugmakers, drugmakers, Robert Davis Organizations: Bristol, Myers Squibb Jardiance, Johnson, Merck, AstraZeneca Entresto, Novartis, Novo Nordisk, Medicare, Centers, Services, Biden, AARP Public, Institute, Congressional, Office, Myers Squibb, Astellas Pharma, U.S . Chamber, Commerce, Supreme, Court, Circuit Court, Pharma, White, Big Pharma Locations: U.S, Bristol

☆ 3M’s $6 bln earplugs settlement is a little sticky
▼ + stars: | 2023-08-29 | by ( ) www.reuters.com time to read: +2 min

A variety of 3M products are pictured at an Orchard Supply Hardware store in Pasadena, California U.S., January 24, 2017. REUTERS/Mario Anzuoni Acquire Licensing RightsNEW YORK, Aug 29 (Reuters Breakingviews) - 3M’s (MMM.N) latest legal settlement includes some curious wrinkles. Moreover, the earplugs agreement is conditioned on 98% participation from what is now roughly 250,000 claimants. The $60 billion company is trying to project the idea it’s getting past its legal entanglements, but the reality is a little stickier. They do not reflect the views of Reuters News, which, under the Trust Principles, is committed to integrity, independence, and freedom from bias.

Persons: Mario Anzuoni, Scotchgard, Jeffrey Goldfarb, Mukesh Ambani’s, Didi, Lauren Silva Laughlin, Sharon Lam Organizations: Supply, Pasadena , California U.S, REUTERS, Reuters, Aearo Technologies, X, Thomson Locations: Pasadena , California

☆ Medicare pricing deal set to play a key role in Biden's 2024 campaign pitch
▼ + stars: | 2023-08-29 | by ( Emma Kinery | ) www.cnbc.com time to read: +1 min

US President Joe Biden speaks about lowering healthcare costs, in the East Room of the White House in Washington, DC, on August 29, 2023. "Boy, we've been fighting Big Pharma for a long time," Biden said Tuesday from the White House. On Tuesday, the White House announced ten prescription drugs that will be subject to the first-ever Medicare price negotiations, which will go into effect in 2026. "Big Pharma [is] charging Americans more than three times what they charge other countries simply because they can," Biden said. Nonetheless, Democrats argue the president should be given a second term to, in Biden's words, "finish the job."

Persons: Joe Biden, we've, Biden, Kamala Organizations: White, WASHINGTON, Centers, Medicare, Services, Big Pharma, White House, Pharma Locations: Washington ,

☆ What the medicare decision means for pharma stocks
▼ + stars: | 2023-08-29 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailWhat the medicare decision means for pharma stocksJared Holz, Mizuho, joins 'Fast Money' to talk the Biden Administration unveiling the first 10 drugs subject to medicare price negotiations and how pharma stocks are responding.

Persons: Jared Holz Organizations: pharma, Biden Locations: Mizuho

☆ NN Group’s deal spree is finally delivering
▼ + stars: | 2023-08-29 | by ( ) www.reuters.com time to read: +2 min

LONDON, Aug 29 (Reuters Breakingviews) - NN Group (NN.AS) is reaping the benefits of scale in its Dutch backyard. Benign weather in the Netherlands, one of the few European states to escape extreme summer weather, helped. But the seeds of NN’s resurgence lie back in 2016 when it began a 3 billion euro deal splurge, first on domestic rival Delta Lloyd and then VIVAT’s general insurance arm. That helped it hike a 10% share of the general insurance market to 24% as of 2021. NN has outperformed its country rival Aegon (AEGN.AS), boosting shareholder returns by 64% since it bought Delta Lloyd in 2016.

Persons: David Knibbe, Elliott Advisors, Elliott, Delta Lloyd, Aimee Donnellan, Mukesh Ambani’s, Didi, George Hay, Oliver Taslic Organizations: Reuters, Chief, Delta, Aegon, Delta Lloyd, Thomson Locations: Netherlands

A general view of the drug product manufacturing laboratory in biologics and sterile injectables, Catalent, in Brussels, Belgium June 27, 2023. The sources declined to be identified because the information is confidential and cautioned a deal could still collapse at the last minute. Spokespeople for Catalent and Elliott declined to comment. In the past when Elliott has pushed for sales of pieces or the entire target company, including at eBay and Switch Inc., and then won board representation, significant ownership changes have followed. Novo Nordisk's weight-loss drug Wegovy is filled by Catalent’s Brussels factory and last week Reuters reported that Catalent’s plant in Bloomington, Indiana will begin filling Wegovy injection pens for Novo.

Persons: Yves Herman Acquire, Elliott, Catalent, Elliott isn't, Keith Meister's, Scott Ferguson's, Mauricio Gutierrez, Svea Herbst, Bayliss, Maggie Fick, Shri Navaratnam Organizations: REUTERS, Catalent, Elliott Investment Management, AstraZeneca, Johnson, Moderna, eBay, Inc, Deutsche Bank, Management, Capital Management, Reuters, NRG, Svea, Thomson Locations: Brussels, Belgium, U.S, Bloomington , Indiana, Novo, Boston, London

A general view of the drug product manufacturing laboratory in biologics and sterile injectables, Catalent, in Brussels, Belgium June 27, 2023. Spokespeople for Catalent and Elliott declined to comment. The U.S.-based contract drugmaker is also Danish company Novo Nordisk's (NOVOb.CO) main manufacturing partner for its popular weight-loss drug Wegovy. The volatility at Catalent could increase scrutiny on the relationship between Novo and its partner. Reuters reported last week that a second Catalent factory will begin filling Wegovy injection pens for Novo as part of an expanded supply agreement.

Persons: Yves Herman Acquire, Elliott, drugmaker, Markus Manns, Catalent, Elliott isn't, Keith Meister's, Scott Ferguson's, Mauricio Gutierrez, Svea Herbst, Bayliss, Maggie Fick, Amanda Cooper, Shri Navaratnam, Bernadette Baum, Catherine Evans Organizations: REUTERS, Elliott Investment Management, Catalent, Novo, Reuters, Union Investment, AstraZeneca, Johnson, Moderna, eBay, Inc, Deutsche Bank, Management, Capital Management, NRG, Svea, Thomson Locations: Brussels, Belgium, U.S, Danish, Novo, United States, Germany, Boston, London

☆ India is warming up to a cooling China
▼ + stars: | 2023-08-28 | by ( Shritama Bose | ) www.reuters.com time to read: +4 min

A screening policy that dramatically slowed investments into India looks ripe for some fine-tuning. India appears to be warming up to a larger Chinese presence in its businesses three years since it introduced an approval regime for investments from countries sharing a land border. Modi has made a deepening financial relationship with China dependent on a warming political one. India is “open” to investments from China, the former’s Minister of State for Electronics and Information Technology Rajeev Chandrasekhar told Financial Times in an interview published in July. Shein is set to re-enter India through a partnership with Reliance Retail, The Wall Street Journal reported in May.

Persons: Narendra Modi’s, Xi Jinping, hamstrung, Sajjan, Modi, Narendra Modi, BYD, Technology Rajeev Chandrasekhar, Sajjan Jindal, Una Galani, Thomas Shum Organizations: Reuters, Indian, pharma, Reuters Graphics Reuters, Authorities, Apple, Reliance Industries, Wall Street, SAIC, Motor India, Economic Times, State, Electronics, Technology, Times, India’s, MG Motor India, Reliance Retail, Street, Bloomberg, Thomson Locations: MUMBAI, South Africa, India, New Delhi, China, Johannesburg, Shanghai

☆ White House inflicts Big Pharma ills
▼ + stars: | 2023-08-28 | by ( ) www.reuters.com time to read: +2 min

If just one or two big medications were going to be renegotiated, the industry could shoulder the change. The IRA, signed into law last year, allows Medicare to negotiate prices for some of its most costly drugs. Though specificities are unclear, a quick look at one of the biggest sellers under the program, blood thinner Eliquis, suggests Big Pharma could shoulder a discount. At 11 times earnings over the next 12 months, that’s less than 10% of the firm’s $205 billion market capitalization. Put this on the same multiple of 11 times, and it would be a $275 billion hit to the industry.

Persons: George Frey, Biden, Robert Cyran, Xpeng’s Didi, Lauren Silva Laughlin, Sharon Lam Organizations: Pfizer Pharmaceuticals, REUTERS, Reuters, Big, Medicare, Pfizer, Bristol, Myers Squibb, Congressional, Office, X, Thomson Locations: Provo , Utah, U.S

☆ This week's most overbought and oversold stocks in the S&P 500 include several pharma names
▼ + stars: | 2023-08-26 | by ( Hakyung Kim | ) www.cnbc.com time to read: +4 min

The relative strength index, which measures the magnitude and speed of price moves, is one way to evaluate whether shares are overbought or oversold. With this in mind, CNBC Pro screened for stocks in the broad market index that fell into overbought and oversold territory this past week. Overbought stocks Here are the ten most overbought stocks for the week. Several technology names made the list of overbought names, suggesting they may soon experience a pullback. Eli Lilly was the most overbought stock in the broad market index this week, with the highest 14-day RSI value of 85.8.

Persons: Jerome Powell's Jackson, Ralph Lauren, DXC, Eli Lilly Organizations: Nasdaq, Dow Jones, CNBC Pro, Citi, Insulet Corp, Citigroup Locations: overbought

☆ The ADHD drug market is already stretched thin. Now it's facing a back-to-school supply strain
▼ + stars: | 2023-08-26 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +8 min

Ten milligram tablets of the hyperactivity drug, Adderall, made by Shire Plc. Adderall and alternative ADHD medications apart from other drugs are Schedule 2 controlled substances. Production limitationsEnding the shortages of Adderall and other ADHD medications is no easy task. That means increasing the production of one drug could potentially require reducing production — and potentially impacting supply — of another drug, according to Ergun. That includes Aytu BioPharma, which makes an ADHD drug that used to be in shortage.

Persons: Jb Reed, It's, Erin Fox, they've, David Margraf, Margraf, drugmakers, Ozlem Ergun, Ergun, Novartis's, Michael Ganio, ASHP's Ganio, RJ Sangosti, Josh Disbrow, Fox Organizations: Shire Plc, Jb, Bloomberg, Getty, and Drug Administration, CNBC, University of Utah, American Society of Health, System Pharmacists, Centers for Disease Control, University of Minnesota's, Infectious Disease, Northeastern University, Teva Pharmaceuticals, Amneal Pharmaceuticals, Sandoz, Purdue Pharma, Rhodes Pharmaceuticals, Drug, Fox, Pharmacists, Drug Enforcement Administration, MediaNews, Denver, FDA, DEA Locations: U.S, Commerce City , Colorado

☆ Exclusive-Bayer investor Artisan calls for breakup of company
▼ + stars: | 2023-08-25 | by ( Richa Naidu | Ludwig Burger | ) www.reuters.com time to read: +4 min

Artisan wants the drugs-to-pesticides company to find new owners for its over-the-counter and pharmaceutical units, it said. Before taking over as CEO, Anderson said he was keeping an open mind on whether to break up the company. Artisan is Bayer’s 16th biggest investor, according to Refinitiv data. Samra said the chairman of Bayer’s supervisory board, Norbert Winkeljohann, has not directly written a letter back to Artisan, but said Artisan had “been in contact” with the company. Samra said Artisan “has not suggested specifically how (Bayer) should restructure their business” in the letter.

Persons: “, Wolfgang Rattay, Bill Anderson, Roche, Anderson, ” David Samra, Bayer, ” Samra, they’re, ” Bayer, Werner Baumann, Samra, Norbert Winkeljohann, China’s Syngenta, Johnson Organizations: Bayer, Artisan Partners, Reuters, Bayer AG, REUTERS, Bluebell Capital Partners, Artisan, Artisan’s, Science, pharma, Johnson, GSK Locations: Leverkusen, Germany, Swiss

☆ Weight-Loss Drug Wegovy Also Works Against Heart Failure
▼ + stars: | 2023-08-25 | by ( Peter Loftus | ) www.wsj.com time to read: 1 min

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/health/pharma/weight-loss-drug-wegovy-also-works-against-heart-failure-a18364e7

Persons: Dow Jones

REUTERS/Shannon Stapleton/File Photo Acquire Licensing RightsLONDON/CHICAGO, Aug 24 (Reuters) - A highly mutated COVID variant called BA.2.86 has now been detected in Switzerland and South Africa in addition to Israel, Denmark, the U.S. and the U.K., according to a leading World Health Organization official. It has since been detected in other symptomatic patients, in routine airport screening, and in wastewater samples in a handful of countries. That the known cases are not linked suggests it is already circulating more widely, particularly given reduced surveillance worldwide, she said. There have been nine such cases detected as of Aug. 23 and the variant was also found in wastewater in Switzerland. Jha and others, including the European public health agency and COVAX, the global program for getting vaccines to the world's poorest, said COVID surveillance and defenses could be reactivated in the event of a major infection wave.

Persons: Shannon Stapleton, Maria Van Kerkhove, Kerkhove, ”, Marion Koopmans, Nirav Shah, Van Kerkhove, Tyra Grove Krause, Ashish Jha, Jha, Jennifer Rigby, Julie Steenhuysen, Pratik Jain, Caroline Humer, Bill Berkrot Organizations: REUTERS, Health Organization, Omicron, WHO, U.S . Centers for Disease Control, Pharmacy, Walgreens, Rite, Reuters, Statens Serum, White, Thomson Locations: Harlem, New York City, U.S, CHICAGO, Switzerland, South Africa, Israel, Denmark, COVID, Dutch, Danish, Bengaluru

A selection of injector pens for the Wegovy weight loss drug are shown in this photo illustration in Chicago, Illinois, U.S., March 31, 2023. REUTERS/Jim Vondruska/Illustration/File Photo Acquire Licensing RightsFRANKFURT, Aug 24 (Reuters) - Supplies of Novo Nordisk's (NOVOb.CO) popular weight-loss drug Wegovy are limited in Germany less than a month after its launch in Europe's largest drug market, major drug distributors and doctors told Reuters. The volumes of the weekly injection that the Danish drugmaker has delivered to the country so far have fallen short of strong demand, the wholesalers said. "Demand is by far exceeding the available volumes," a spokesperson for Noweda, which has almost a quarter of the German drug wholesale trade, told Reuters, adding the problem was nationwide. The distributors, which act as go-betweens for drug companies and pharmacies, declined to give details of volumes.

Persons: Jim Vondruska, Thomas Horbach, Sanacorp, Pharmahandel, Pharma Privat, Helios St, Elisabeth Klinik, Jodok Fink, ”, Ludwig Burger, Maggie Fick, Josephine Mason, Mark Potter Organizations: REUTERS, Rights, Reuters, Noweda, Novo, Pharma, Thomson Locations: Chicago , Illinois, U.S, Novo, Germany, Europe, Munich, Oberhausen, Freiburg, Frankfurt, London

☆ FDA Approves RSV Vaccine to Pass Protection From Mother to Child
▼ + stars: | 2023-08-21 | by ( Jared S. Hopkins | ) www.wsj.com time to read: 1 min

Persons: Dow Jones, bf7aaf24 Organizations: pharma, fda, pfizer

☆ Why startups are investing millions to make drugs and semiconductors in space
▼ + stars: | 2023-08-20 | by ( Magdalena Petrova | ) www.cnbc.com time to read: +4 min

Now, several space startups see an opportunity to satisfy in-space manufacturing demand using compact space factories. One company is Varda Space Industries in Southern California. Varda Space Industries' first pharmaceutical manufacturing satellite and reentry vehicle attached to a Rocket Lab Photon bus. Years of research have shown that protein crystals grown in space are much higher quality than those grown on Earth. Across the Atlantic in Cardiff, Wales, Space Forge is working on designing its own in-space factory to manufacture next-generation semiconductors.

Persons: Ilan Rozenkopf, Joe Biden, Varda, Asparouhov, we've, Andrew Parlock Organizations: pharma, McKinsey . Space, NASA, ISS, Varda Space Industries, Pfizer, Space Locations: vacuumless, Southern California, U.S, Cardiff , Wales, Space Forge's

☆ Gilead Sciences Is the Target of a Bizarre Legal Theory
▼ + stars: | 2023-08-19 | by ( The Editorial Board | ) www.wsj.com time to read: 1 min

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/articles/gilead-sciences-lawsuit-hiv-drug-tdf-taf-pharma-innovation-ef2ea514

Persons: Dow Jones Organizations: pharma Locations: gilead, taf

☆ Rudy Giuliani helped Purdue Pharma keep selling OxyContin. Here's the real story behind what's depicted in 'Painkiller.'
▼ + stars: | 2023-08-18 | by ( Erin Snodgrass | ) www.businessinsider.com time to read: +4 min

Giuliani helped Purdue Pharma strike a deal with the government to keep selling the drug. Purdue Pharma hired Giuliani back in 2002, representing the first client his consulting firm ever landed, The New York Times reported in 2007. By getting Brownlee to agree to prosecute the parent company, Purdue Frederick, rather than Purdue Pharma, Giuliani and his team were also able to prevent a ban against Purdue Pharma doing future business with the federal government, which manages public health programs like Medicaid, Medicare, and the Veterans Administration health system, The Guardian reported. Under our settlement, Purdue Pharma would cease to exist and Knoa Pharma, a newly formed company with a public-minded mission, would emerge. The settlement would deliver over $10 billion of value for opioid crisis abatement, overdose rescue medicines, and victim compensation."

Persons: Trump, Rudy Giuliani, Giuliani, — Rudy Giuliani, Sackler, OxyContin, Edie Flowers, Uzo Aduba, Patrick Radden Keefe, John Brownlee's, James Comey, Brownlee, who'd, Purdue Frederick Organizations: Netflix, Former New York City Mayor, Purdue Pharma, Service, Purdue, New, New York City, OxyContin, The New York Times, Guardian, Veterans Administration, Knoa Pharma Locations: Wall, Silicon, New York, New York City, OxyContin

☆ The ‘Public Nuisance’ Menace
▼ + stars: | 2023-08-17 | by ( David B. Rivkin Jr. | O.H. Skinner | ) www.wsj.com time to read: 1 min

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/articles/public-nuisance-gun-pharma-car-theft-pollution-fossil-fuels-trial-lawyer-settlement-abuse-power-f45a8581

Persons: Dow Jones Organizations: pharma

Search resuls for: "PHARMA"

25 mentions found